Balance Sheet
Cash Flow Statement
AmortizationAmortizationAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in CashExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet Income
Growth Metrics
Income Statement
Others
Ratios

Avricore Health (AVCRF) Capital Expenditures (2016 - 2025)

Avricore Health has reported Capital Expenditures over the past 8 years, most recently at -$2979.5 for Q4 2025.

  • Quarterly Capital Expenditures rose 22.11% to -$2979.5 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$62271.0 through Dec 2025, up 53.28% year-over-year, with the annual reading at -$63339.2 for FY2025, 52.11% up from the prior year.
  • Capital Expenditures was -$2979.5 for Q4 2025 at Avricore Health, up from -$11451.0 in the prior quarter.
  • Over five years, Capital Expenditures peaked at $1.4 million in Q4 2022 and troughed at -$465996.9 in Q3 2022.
  • The 5-year median for Capital Expenditures is -$37978.6 (2021), against an average of $5936.7.
  • The largest YoY upside for Capital Expenditures was 789.45% in 2022 against a maximum downside of 926.92% in 2022.
  • A 5-year view of Capital Expenditures shows it stood at $162130.9 in 2021, then soared by 789.45% to $1.4 million in 2022, then tumbled by 117.49% to -$252185.1 in 2023, then surged by 98.48% to -$3825.5 in 2024, then increased by 22.11% to -$2979.5 in 2025.
  • Per Business Quant, the three most recent readings for AVCRF's Capital Expenditures are -$2979.5 (Q4 2025), -$11451.0 (Q3 2025), and -$1275.3 (Q2 2025).